Retro Biosciences (@RetroBio_) — Twitter Score 19 out of 1000

Retro Biosciences is a longevity biotechnology company co-founded to add 10 years to healthy human lifespan. Retro Biosciences's Twitter Score is 19 out of 1000 as of August 2026, ranking #51,577 among 483,944 tracked accounts.

Retro Biosciences was co-founded by Joe Betts-LaCroix, who serves as CEO, alongside Matt Buckley and Sheng Ding. The company emerged from stealth with $180 million in funding, establishing itself as one of the better-capitalized entrants in the longevity medicine space. 4P Capital led a subsequent financing round in 2026, and Sam Altman is among the company's backers.

Retro Biosciences focuses on developing therapies targeting age-related diseases, with a pipeline that spans cell therapy, protein engineering, and small-molecule approaches. In 2025, the company advanced RTR242, an oral therapeutic designed to restart autophagy, into a Phase I clinical trial. To support its programs, Retro Biosciences built an in-house cGMP cell-therapy manufacturing facility alongside AI-enabled protein-engineering capabilities.

Retro Biosciences collaborates with OpenAI on protein redesign research. Per OpenAI, proteins redesigned through that collaboration produced a greater than 50-fold increase in expression of stem-cell reprogramming markers in vitro. Retro Biosciences also maintains a research partnership with the Murdoch Children's Research Institute. The account has published 67 posts and has been mentioned by 10 accounts a total of 18 times.

Who follows Retro Biosciences on X?

The accounts that follow Retro Biosciences include 74 founders, 26 angel investors and 16 influencers, among them Brian Armstrong, 6529, Eric Wall, Cuy Sheffield, Olaf and Julien B.